CAO, Zhu Alexander,SACI, Abdel,VANASSE, K. Gary J.,GROWNEY, Joseph Daniel
申请号：
HK16110653.9
公开号：
HK1222539A
申请日:
2016.09.07
申请国别(地区):
HK
年份:
2017
代理人:
摘要：
The present invention relates to a Pim kinase inhibitor compound that can be used alone or in a pharmaceutical combination. One such combination comprises (a) a JAK inhibitor compound, (b) a Pim kinase inhibitor compound, and optionally, at least one pharmaceutically acceptable carrier for simultaneous, separate or sequential use, in particular for the treatment of a myeloid neoplasm or leukemia a pharmaceutical composition comprising such a combination the use of such a combination for the preparation of a medicament for the treatment of myeloid neoplasm or leukemia a commercial package or product comprising such a combination as a combined preparation for simultaneous, separate or sequential use and to a method of treatment of a mammal, especially a human.
